跳至主要内容
临床试验/NCT05052476
NCT05052476已完成不适用

First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic

Astel Medica1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2022年4月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
68
试验地点
1
主要终点
Change in parent quality of life (QoL) score

研究概览

简要总结

This randomized, open label, dose-response study will be realized at the first line with Bactecal® D Liquid. The objective is to investigate Bactecal® D Liquid in the context of infantile colics.

The patients will be randomized into two arms, A and B, in function of the intervention dose. The quality of life of te parents as well as the daily median crying time and the number of daily crying will be assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Weeks 至 8 Weeks(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Full term healthy infant (37-41 weeks amenorrhea)
  • •Birth weight >2750 g
  • •Aged between 2 and 8 weeks
  • •Presenting symptoms of infant colic as defined by Rome IV criteria by Zeevenhoven et al. 2017
  • •Signed written informed consent of the parent/tutor

排除标准

  • •Premature birth
  • •Using probiotics as a treatment, different from the one that could contain the formula at the time of study recruitment
  • •Acute or chronic illness as judged by the investigator which avoids the participation to the study .
  • •Parents unable to understand the requirements of study participation as judged by the investigator
  • •Malnutrition as judged by a body weight/height ratio <5 %

研究组 & 干预措施

Open label Bactecal® D Liquid 1 dose

Experimental

Patients will receive 1 dose of Bactecal® D Liquid by day which corresponds to 2 ml of product

干预措施: Bactecal® D Liquid (Dietary Supplement)

Open label Bactecal® D Liquid 2 doses

Experimental

Patients will receive 2 doses of Bactecal® D Liquid by day which correspond to 4 ml of product.

干预措施: Bactecal® D Liquid (Dietary Supplement)

结局指标

主要结局

Change in parent quality of life (QoL) score

时间窗: Change from baseline parent QoL score at 28 days

By measuring parent quality of Life (QoL) score. Scale from 1 (minimum) to 7 (maximum). Higher scores mean a better outcome.

次要结局

  • Change of the number of crying(Change from baseline number of crying at 28 days)
  • Change of daily median crying time(Change from baseline daily median crying time at 28 days)

研究者

发起方
Astel Medica
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验